Registry for patients undergoing coronary intervention with orbital atherectomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Lower Silesian Orbital Atherectomy Registry (LOAR) is an observational registry that collects data on patients with severely calcified coronary lesions who undergo percutaneous coronary intervention (PCI) using the Orbital Atherectomy Device. The study involves two cardiac centers in Poland, where consecutive cases are documented to assess safety and efficacy. Patients are selected based on clinical indications and the severity of calcification, which is evaluated through angiographic or intravascular imaging techniques. Informed consent is obtained from all participants after discussing the risks and benefits of the procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The presence of moderately to severely calcified lesions.

Exclusion Criteria:

* Lack of patient consent
* Target vessel perforation due to previous unsuccessful lesion preparation
* Pregnancy

Where it's running

• Department of Cardiology, Provincial Specialized Hospital in Legnica
  Legnica, Lower Silesian Voivodeship, Poland Recruiting
• Department of Cardiology, The Copper Health Centre (MCZ)
  Lubin, Lower Silesian Voivodeship, Poland Recruiting

Study contacts

• Study coordinator: Piotr Rola, MD; PhD
• Email: piotr.rola@gmail.com
• Phone: +48767211446

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for patients with refractory angina undergoing Coronary Sinus Reducer implantation

  This study is testing if a new device called the Coronary Sinus Reducer can help people with severe chest pain who haven't found relief from other treatments.

  Recruiting at 2 sites Miedziowe Centrum Zdrowia SA · Lubin, Lower Silesian Voivodeship and 1 other locations · NCT06288165

• Evaluating bifurcation coronary interventions using two techniques

  This study looks at how well two different stenting techniques work for patients with heart artery blockages to see which one is safer and more effective.

  Recruiting at 2 sites Miedziowe Centrum Zdrowia SA · Legnica, Lower Silesian Voivodeship and 1 other locations · NCT06284057

• Registry of patients undergoing coronary interventions with shockwave therapy

  This study is collecting information on patients with hard blockages in their heart arteries who are getting a new shockwave treatment to see how safe and effective it is.

  Recruiting at 2 sites Miedziowe Centrum Zdrowia SA · Legnica, Lower Silesian Voivodeship and 1 other locations · NCT05916898

• Switching to Tenofovir Alafenamide for Chronic Hepatitis B Treatment

  This study is testing if switching chronic hepatitis B patients from their current medication to a new one called tenofovir alafenamide can make them happier with their treatment and help them stick to it better.

  Recruiting Taichung Veterans General Hospital · Taichung, Taiwan · NCT05583006

• Comparing two treatments for femoropopliteal artery disease

  This study tests whether a special balloon treatment or a stent works better for people with blocked arteries in their legs.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT05517291

• Empagliflozin with or without metformin for safety and tolerability in adults with Type 2 diabetes

  This project will try empagliflozin, with or without metformin, in adults with Type 2 diabetes to see if it is safe and well tolerated in routine clinical care at participating centers.

  Recruiting at 2 sites Phase 4 Getz Pharma · Kabul, Afghanistan and 5 other locations · NCT05164263

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.